Evidence map›Paper›PMID 33785354›Full record

ArticleToxicology and applied pharmacology2021

Functional characterization of N-octyl 4-methylamphetamine variants and related bivalent compounds at the dopamine and serotonin transporters using Ca

Iwona Ruchala, Umberto M Battisti, Vy T Nguyen, Rita Yu-Tzu Chen, Richard A Glennon, Jose M Eltit

Abstract readComparative Study
In one paragraph

Article in Toxicology and applied pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Iwona RuchalaDepartment of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, United States of America.
Umberto M BattistiDeparment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, United States of America.
Vy T NguyenDepartment of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, United States of America.
Rita Yu-Tzu ChenDepartment of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, United States of America.
Richard A GlennonDeparment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, United States of America.
Jose M EltitDepartment of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, United States of America. Electronic address: jose.eltit@vcuhealth.org.

Funding

Synthetic cathinones: a new class of illicit drugs affecting DAT & SERTR01DA033930 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI ELTIT, JOSE MIGUEL, GLENNON, RICHARD A · 2012 to 2016
$2.7M
Pharmacology of Stimulant ChoiceR01DA055825 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI Matthew L Banks, Jose Miguel Eltit · 2023 to 2026
$1.4M
NIDA NIH HHS R01 DA033930NIDA NIH HHS R01 DA055825
6 · The paper itself

Abstract

The early characterization of ligands at the dopamine and serotonin transporters, DAT and SERT, respectively, is important for drug discovery, forensic sciences, and drug abuse research. 4-Methyl amphetamine (4-MA) is a good example of an abused drug whose overdose can be fatal. It is a potent substrate at DAT and SERT where its simplest secondary amine (N-methyl 4-MA) retains substrate activity at them. In contrast, N-n-butyl 4-MA is very weak, therefore it was categorized as inactive at these transporters. Here, N-octyl 4-MA and other related compounds were synthesized, and their activities were evaluated at DAT and SERT. To expedite this endeavor, cells expressing DAT or SERT were co-transfected with a voltage-gated Ca

Indexed as

Biosensing TechniquesCalciumCalcium ChannelsDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsGreen Fluorescent ProteinsHEK293 CellsHumansMethamphetamineMicroscopy, FluorescenceMolecular StructureSelective Serotonin Reuptake InhibitorsSerotonin Plasma Membrane Transport ProteinsStructure-Activity RelationshipTime FactorsCalciumCalcium ChannelsDopamine Plasma Membrane Transport ProteinsDopamine Uptake Inhibitorsenhanced green fluorescent proteinGreen Fluorescent ProteinsMethamphetamineSelective Serotonin Reuptake InhibitorsSerotonin Plasma Membrane Transport ProteinsSLC6A3 protein, humanSLC6A4 protein, humanCalcium imagingMonoamine transportersPsychostimulantsReuptake inhibitorsVoltage-gated calcium channels

Identifiers

PMID33785354
PMCPMC8148225

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.